Exemption Involving Hawai'i Pacific Health and Its Subsidiary: Straub Clinic & Hospital Located in Honolulu, Hawaii
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
This exemption permits the Hawai[revaps]i Pacific Health Retirement Plan (the Plan) to sell property (the Property) to Straub Clinic & Hospital (Straub) for the greater of $16,247,000 or 110% of the Appraised Value of the Property as of the date of the sale (the Sale). Absent this exemption, the Sale would violate certain prohibited transaction restrictions of the Employee Retirement Income Security Act of 1974 (ERISA) and/or the Internal Revenue Code of 1986 (the Code).
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 161 (Friday, August 21, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 161 (Friday, August 21, 2026)]
[Notices]
[Pages 54383-54387]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-17142]
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Employee Benefits Security Administration
[Prohibited Transaction Exemption 2026-05; Application Number D-12082]
Exemption Involving Hawai[revaps]i Pacific Health and Its
Subsidiary: Straub Clinic & Hospital Located in Honolulu, Hawaii
AGENCY: Employee Benefits Security Administration, Labor.
ACTION: Notice of exemption.
-----------------------------------------------------------------------
SUMMARY: This exemption permits the Hawai[revaps]i Pacific Health
Retirement Plan (the Plan) to sell property (the Property) to Straub
Clinic & Hospital (Straub) for the greater of $16,247,000 or 110% of
the Appraised Value of the Property as of the date of the sale (the
Sale). Absent this exemption, the Sale would violate certain prohibited
transaction restrictions of the Employee Retirement Income Security Act
of 1974 (ERISA) and/or the Internal Revenue Code of 1986 (the Code).
DATES: This final exemption is effective August 21, 2026.
FOR FURTHER INFORMATION CONTACT: Nicholas Schroth, Office of Exemption
Determinations, Employee Benefits Security Administration, U.S.
Department of Labor, (202) 693-8540 (this is not a toll-free number).
SUPPLEMENTARY INFORMATION: Hawai[revaps]i Pacific Health (the
Applicant) requested an exemption pursuant to ERISA section 408(a) and
Code section 4975(c)(2) in accordance with the Department's exemption
procedures set forth in 29 CFR part 2570, subpart B.\1\ After reviewing
the application, the Department tentatively determined that the Sale
would be in the interest of, and protective of, the Plan and its
participants and beneficiaries, and would also be administratively
feasible, because, among other things: (1) a qualified independent
fiduciary (QIF) would protect the Plan's interests with respect to the
Sale; and (2) the Plan would receive at least 110% of the Appraised
Value for the Property. The term Appraised Value means the greater of
the Property's ``fair market value'' or its ``Investment Value,'' \2\
as of the date of the Sale, as determined by a Qualified Independent
Appraiser (QIA).
---------------------------------------------------------------------------
\1\ 29 CFR part 2570, subpart B (76 FR 66637 (October 27,
2011)). The Department's exemption procedures regulation was amended
at 89 FR 4662, on January 24, 2024, with an effective date of April
8, 2024. However, because the application was submitted on December
5, 2022, the procedures in effect as of that date govern. Effective
December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978,
5 U.S.C. App. 1 (1996), transferred the authority of the Secretary
of the Treasury to issue exemptions of the type requested by the
Applicant to the Secretary of Labor. Therefore, this notice of
exemption is issued solely by the Department. For purposes of this
exemption, references to ERISA section 406, unless otherwise
specified, should be read to refer as well to the corresponding
provisions of Code section 4975.
\2\ For purposes of this exemption, Investment Value means the
value of a property to a particular investor or class of investors
based on the investor's specific requirements.
---------------------------------------------------------------------------
On November 26, 2025, the Department proposed an exemption that
would permit the Sale, subject to certain conditions (the Proposed
Exemption),\3\ and invited interested persons to submit written
comments and/or requests for a public hearing. All comments and
requests for a hearing were due to the Department by January 16, 2026.
The Department received sixty-five written comments from individuals
and one written comment from the Hawai[revaps]i Nurses' Association,
OPEIU Local 50 (Local 50) (collectively, the Commenters). Discussed
below are the issues raised by the Commenters and responses to these
issues raised by Central Pacific Bank (CPB), the Plan's QIF. Also
discussed below is the Commenters' request for a hearing and the
Department's response to that request.
---------------------------------------------------------------------------
\3\ 90 FR 54387.
---------------------------------------------------------------------------
Comment #1. The Proposal does not explain why the Property was not
put up for sale on the open market, which could produce a higher or
better offer for the Plan than what the appraiser estimated the
Property is worth.
CPB Response to Comment #1. The open market option was not
preferred because Straub offered to buy the Property at a price that
exceeded what the Property is expected to sell for on the open market.
CPB's appraiser
[[Page 54384]]
estimated that the fair market value of the Property was $13,030,000 as
of April 1, 2024. At the Department's urging, CPB negotiated an
increased Sale price of $14,770,000, based on the Property's appraised
Investment Value. CPB further negotiated an additional amount over the
Investment Value, which increased the purchase price of the Property to
$16,247,000. CPB's appraiser also opined that an open market buyer
would be unlikely to make an offer that exceeds the Property's fair
market value due to the Property's features, such as the Property's
irregular shape, its existing long-term lease, and its zoning
restrictions.
Department Response to Comment #1. The Department considered this
issue during its review of the exemption application. After
reevaluating the merits of the Sale following the publication of the
Proposed Exemption, including the written comment from Local 50, the
Department remains of the view that the Sale would provide a greater
return to the Plan than a sale of the Property on the open market.
Importantly, the Plan will receive a price that is the greater of
$16,247,000 or 110% of the Appraised Value of the Property as of the
date of the Sale.
Comment #2. The appraisal relies on assumptions that may exclude
strategic value unique to the affiliated buyer, and the Plan owning the
land below the yet-to-be-built hospital would increase its value on the
open market.
CPB Response #2. The increased value associated with Straub's
intention to build a hospital is incorporated into the Investment Value
estimate. Further, the assumptions set forth in the Property's
appraisal were developed in accordance with recognized valuation
methodologies and are consistent with prevailing professional
standards. Each assumption in the appraisal reflected established
industry norms and accepted analytical practices.
Department's Response #2. The Department considered this issue
during its review of the exemption application. As noted above, in
order to capture the unique value that the Property holds for Straub,
the exemption requires that the Plan receive the greater of $16,247,000
or 110% of the Appraised Value of the Property as of the date of the
Sale. For purposes of this exemption, the Appraised Value of the
Property means the greater of the Property's ``fair market value'' or
its ``Investment Value,'' as determined by a QIA. The Property's
Investment Value takes into account the Property's unique value to
Straub and, presently, increases the Property's value relative to its
fair market value. In this way, the Plan will receive the unique value
of the Property with respect to Straub.
Comment #3. The Commenters state that the Proposed Exemption does
not show that the Sale is in the best interest of the Plan compared to
reasonable alternatives, such as selling through a competitive process
or continued ownership by the Plan.
Department's Response #3. The competitive process issue is
discussed in Response #1 above. To assess the Commenter's argument that
continued ownership of the Property by the Plan would be in the Plan's
best interest as opposed to the Sale, the Department reviewed the
Property's April 22, 2024, appraisal (2024 Appraisal). One of the
valuation methodologies analyzed in the 2024 Appraisal was the Income
Capitalization Approach (i.e., valuing the present worth of anticipated
future income projected to be derived from the Plan's continued
ownership of the Property). To determine the likely highest dollar
value to the Plan between continued leasing of the Property and selling
the Property, the Department compared: (1) the QIA's estimated present
value of future income to the Plan by continued ownership of the
Property; with (2) the negotiated purchase price of the Property.
The 2024 Appraisal shows that the negotiated purchase price for the
Property ($16,247,000) would likely be greater than the estimated value
to the Plan due to its continued ownership of the Property
($14,770,000). Thus, the Sale would provide the estimated highest value
to the Plan between the two options. The conditions of this exemption
further protect the Plan by requiring the purchase price formula for
the Sale to be the greater of $16,247,000 or 110% of the Appraised
Value (i.e., the higher of the market value or Investment Value) as of
the date of the Sale. Finally, the record shows that CPB determined
that the Sale was the most prudent course of action, given the Plan's
objectives and financial situation.
Comment #4. The Commenters note that Straub has not paid back all
the property expenses the Plan erroneously paid on Straub's behalf, in
connection with the Plan's erroneous payment of Property taxes,
utilities, and maintenance from 2006 to 2022 (Property Expenses). The
Commenters state that this mistake means that Straub should not be
trusted with a Sale without testing the open market to confirm the
Property's value. Separately, one Commenter suggested that potential
collusion exists between the Plan sponsor and related parties and notes
that the Plan may be hiding additional operational failures.
CPB's Response #4. CPB notes that Condition (g) of the Proposed
Exemption requires Straub (or Hawai[revaps]i Pacific Health) to repay
the Plan all of the Property Expenses from 2006 to 2022.
Department's Response #4. Prior to publication of the Proposed
Exemption: Straub repaid the Property Expenses owed to the Plan, plus
interest, for years 2015 to 2022; and the Department confirmed that the
amount repaid at least equaled the amount owed the Plan for years 2015
to 2022.
Following publication of the proposed exemption, Hawai[revaps]i
Pacific Health repaid (on behalf of Straub) the Property Expenses owed
to the Plan, plus interest, for years 2006 to 2014. Section III(b)(7)
of this exemption requires the QIF to confirm in writing to the
Department that the amount repaid at least equaled the amount owed the
Plan for years 2006 to 2014.\4\
---------------------------------------------------------------------------
\4\ Prior to publishing the Proposed Exemption, the Department
confirmed that Hawai'i Pacific Health repaid the correct amount of
Property Expenses and interest to the Plan for years 2015 to 2022.
---------------------------------------------------------------------------
Comment #5. Local 50 states that by ``conducting a closed sale of
the land to the plan sponsor the plan is providing a material benefit
to the plan sponsor without receiving appropriate compensation'' and
that the ``right of first refusal is a consideration that should
require compensation in a transaction that places the Plan participants
first.'' The Commenters further provide that the Sale should be
disallowed and an investigation into the Sale, the trustees, and the
Plan sponsor should be conducted.
CPB's Response #5. In response to the argument that the proposed
Sale constitutes an ``uncompensated benefit to the plan sponsor,'' CPB
notes that the proposed price includes both an Investment Value premium
(which reflects the Property's enhanced value specifically to Straub
due to Straub's unique position as the adjoining landowner) and an
additional 10% above the Property's appraised Investment Value.
Department's Response #5. The terms of the Sale were closely
evaluated by the Department during its processing of the application,
including the Sale price and its component, Investment Value. The
Comment did not raise any new facts that would lead the Department to
question whether the Plan will receive appropriate compensation.
Further, the Department has found no evidence that a right of first
refusal exists on this Property--only that the Plan intends to sell the
Property to Straub. Finally, the Commenters provided no additional
[[Page 54385]]
facts that support an investigation into the Sale, the Trustees, or the
Sponsor.
Hearing Request. Local 50 and the vast majority of the individual
commenters requested a hearing to address the concerns above and to
ensure the transaction's alignment with the interests of the Plan
participants.
Department's Response to the Hearing Request. As noted in the
Proposed Exemption, the Department's procedural regulations provide for
a hearing when ``necessary to fully explore material factual issues
identified by the person requesting the hearing.'' \5\ The Department's
regulations also provide that it may decline to hold a hearing if,
among other things, ``the factual issues identified can be fully
explored through the submission of evidence in written (including
electronic) form.'' None of the comments received raised any factual
issues that were not already considered by the Department in its
evaluation of the exemption application, and no commenter identified
any issues that cannot be fully explored through the submission of
evidence in written form. The Department therefore declines to hold a
hearing.
---------------------------------------------------------------------------
\5\ 29 CFR part 2570, subpart B (75 FR 66637, October 27, 2011).
---------------------------------------------------------------------------
The Department notes that in processing the Applicant's exemption
request, it thoroughly reviewed the application, all materials
submitted in support of the application, and all comments received
during the comment period. A complete copy of the record supporting
this exemption is available in the Department's Public Disclosure Room
by referencing Application No. D-12082.
Other Changes
This final exemption also includes minor, non-substantive edits
intended to correct scrivener's errors or make non-substantive
clarifications.
Statutory Findings
Based on the entire record, including the comments discussed above,
the Department has determined to grant the proposed exemption. In this
regard, the Department makes the requisite findings under ERISA section
408(a), based on the Applicants' adherence to all the conditions and
definitions of the exemption at all times. Accordingly, affected
parties should be aware that the conditions and definitions
incorporated in this exemption are, taken individually and as a whole,
necessary for the Department to grant the relief requested by the
Applicant. In granting this exemption, the Department has relied on the
representations of the Applicant. If any material statement in the
Application, supporting documents (including the Applicant's comment),
Proposed Exemption or final exemption is not, or may no longer be,
completely and factually accurate, the Applicant and recipients of the
exemptive relief provided herein must immediately alert the Department.
The complete application file (D-12082) will remain available for
public inspection in the Public Disclosure Room of the Employee
Benefits Security Administration, Room N-1515, U.S. Department of
Labor, 200 Constitution Avenue NW, Washington, DC 20210 reachable by
telephone at (202) 693-8673. For a more complete statement of the facts
and representations supporting the Department's decision to grant this
exemption, please refer to the Proposed Exemption.
General Information
The attention of interested persons is directed to the following:
(1) The fact that a transaction is the subject of an exemption
under ERISA section 408(a) and/or Code section 4975(c)(2) does not
relieve a fiduciary or other party in interest or disqualified person
from certain other provisions of ERISA and/or the Code, including any
prohibited transaction provisions to which the exemption does not apply
and the general fiduciary responsibility provisions of ERISA section
404, which, among other things, require a fiduciary to discharge their
duties respecting the plan solely in the interest of the participants
and beneficiaries of the plan and in a prudent fashion in accordance
with ERISA section 404(a)(1)(B); nor does it affect the requirement of
Code section 401(a) that the Plan must operate for the exclusive
benefit of the employees of the employer maintaining the Plan and their
beneficiaries;
(2) As required by ERISA section 408(a), the Department hereby
finds that the exemption is (1) administratively feasible for the
Department, (2) in the interests of affected plans and of their
participants and beneficiaries, and (3) protective of the rights of
participants and beneficiaries of such Plans;
(3) The exemption is supplemental to, and not in derogation of, any
other ERISA provisions, including statutory or administrative
exemptions and transitional rules. Furthermore, the fact that a
transaction is subject to an administrative or statutory exemption is
not dispositive of determining whether the transaction is in fact a
prohibited transaction; and
(4) The availability of this exemption is subject to the express
condition that the material facts and representations contained in the
application accurately describe all material terms of the transactions
that are the subject of the exemption and are true at all times.
Accordingly, after considering the entire record developed in
connection with the Applicant's exemption application, the Department
has determined to grant the following exemption under the authority of
ERISA section 408(a) and Code section 4975(c)(2) in accordance with the
Department's exemption procedures regulation.
Exemption
Section I. Definitions
(a) ``Appraised Value'' means the greater of the Property's fair
market value or its Investment Value, as determined by the QIA.
(b) ``Investment Value'' means the value of a property to a
particular investor or class of investors based on the investor's
specific requirements. In the instant case, Lesher, the Qualified
Independent Appraiser, considered the potential benefit to Straub for
purchasing the Property taking into account the fact that Straub owned
an abutting parcel of real estate.
(c) ``Plan'' means the Hawai'i Pacific Health Retirement Plan, a
defined benefit plan that provides retirement benefits to Hawai'i
Pacific Health employees and the employees of Straub Clinic & Hospital.
Hawai'i Pacific Health appointed the Hawai'i Pacific Health Retirement
Plan Finance Committee (the Committee) to serve as the Plan's named
fiduciary and plan administrator.
(d) The ``Property'' means the parcel of real property owned by the
Plan and located at 888 South King Street, Honolulu, HI 96813.
(e) ``Property Expenses'' mean the expenses and costs relating to
the Property that Straub was responsible to pay pursuant to several
provisions in the lease between Straub and the Plan, dated January 2,
1969. These costs and expenses include taxes, utilities, and
maintenance.
(f) ``Purchase Price'' means the price paid by Straub to the Plan
for the Property, which must be the greater of $16,247,000 or 110% of
the Appraised Value as determined by the QIA on the date of Sale. This
amount may be further negotiated upwards by the QIF if necessary to
determine that the Sale is in the best interest of the Plan.
(g) ``Qualified Appraisal Report'' means the report appraising the
Property as of the Sale date that comports with the requirements of 29
CFR 2570.31(h).
[[Page 54386]]
(h) ``QIA'' means Lesher Chee Stadlbauer (Lesher), or such other
``Qualified Independent Appraiser,'' as defined in 29 CFR 2570.31(i),
hired by the QIF to determine the Property's Appraised Value as of the
date of the Sale. If the QIF replaces Lesher with a new entity to act
as the QIA in connection with the Sale, the new entity must be approved
in writing by the Department, and the Department must receive a copy of
the new appraiser's appraisal report for the Property at least 60 days
in advance of the Sale.
(i) ``QIF'' means Central Pacific Bank (CPB), or such other
``Qualified Independent Fiduciary,'' as defined in 29 CFR 2570.31(j),
hired by the Plan to monitor, review, negotiate, and exercise the sole
authority to approve the Sale of the Property in accordance with the
requirements of ERISA section 404(a) and 404(b), and this exemption, if
granted. If the Plan replaces CPB with a new entity to serve as the QIF
in connection with the Sale, the new entity must be approved in writing
by the Department at least 90 days in advance of the Sale.
(j) ``Straub'' means Straub Clinic & Hospital, a wholly controlled
subsidiary of Hawai[revaps]i Pacific Health, the employees of which are
participants in the Plan.
Section II. Transactions
This exemption provides relief from the prohibited transactions
provisions of ERISA sections 406(a)(1)(A), 406(a)(1)(D), 406(b)(1), and
406(b)(2), and Code sections 4975(c)(1)(A), (D), and (E) for
Hawai[revaps]i Pacific Health and the Committee in connection with the
sale of the Property by the Plan to Straub in exchange for a lump sum
payment of cash equal to the Purchase Price (the Sale). To receive this
relief, the conditions in Section III must be met in conformance with
the definitions in Section I.
Section III. Conditions
(a) The Sale must be a lump sum payment in cash equal to the
Purchase Price, and the Sale must take place within 60 days of the date
of publication of the exemption in the Federal Register.
(b) The QIF must have the sole authority to approve the Sale and
take any other fiduciary action on behalf of the Plan with respect to
the Sale; and the QIF must take the following actions in accordance
with its fiduciary responsibilities under ERISA Section 404(a) and (b):
(1) Determine whether it is prudent to go forward with the Sale and
make a final determination on the record whether or not to proceed with
the Sale;
(2) Approve the terms and conditions of the Sale;
(3) Retain the services of a QIA, review the Qualified Appraisal
Report, approve the methodology used by the QIA, and ensure that such
methodology is properly applied in determining the Property's fair
market value and Investment Value on the date of the Sale;
(4) Negotiate a higher price than the current Purchase Price, if
necessary, in order to determine that the Sale is in the best interest
of the Plan and its participants and beneficiaries;
(5) Monitor the Sale throughout its duration on behalf of the Plan
to ensure the parties' compliance with the terms of applicable sale
agreements and related documents and enforce the rights of the Plan and
its participants and beneficiaries in connection with such agreements;
(6) Monitor compliance with the conditions for this exemption and
take any appropriate actions to safeguard the interests of the Plan and
its participants and beneficiaries;
(7) Review and approve in writing, prior to approving the Sale,
that the amounts of Property Expenses erroneously paid by the Plan from
2006 through 2014, with associated lost interest as calculated using
the Department's VFCP Calculator, have been repaid on behalf of Straub
to the Plan to make the Plan whole, using the Department's applicable
correction procedures; \6\
---------------------------------------------------------------------------
\6\ See 29 CFR parts 2560 and 2570, most recently amended in the
Federal Register at 90 FR 4192 (January 15, 2025). The Department's
VFCP Calculator can be found online at <a href="https://www.dol.gov/agencies/ebsa/employers-and-advisers/plan-administration-and-compliance/correction-programs/vfcp/calculator">https://www.dol.gov/agencies/ebsa/employers-and-advisers/plan-administration-and-compliance/correction-programs/vfcp/calculator</a>.
---------------------------------------------------------------------------
(8) Create and deliver to the Department a report (i) justifying
its conclusion that the Sale is, or is not, in the best interest of the
Plan and its participants and beneficiaries, and was conducted in
accordance with the terms of this exemption, (ii) confirming that the
calculation and repayment of the Property Expenses described in the
preamble to the notice of proposed exemption \7\ and associated lost
interest were, or were not, accurately repaid, and (iii) confirming
that the conditions of the exemption have, or have not, been satisfied
with copies of any applicable reports needed to make the confirmations.
The report must be delivered to the Department within 60 days after the
Sale, or the date the QIF determines that the Sale is not in the
interest of the Plan, at <a href="/cdn-cgi/l/email-protection#b2d79ffdf7f6f2d6ddde9cd5ddc4"><span class="__cf_email__" data-cfemail="d0b5fd9f959490b4bfbcfeb7bfa6">[email protected]</span></a>.
---------------------------------------------------------------------------
\7\ 90 FR 54387, 54388 (November 26, 2025).
---------------------------------------------------------------------------
(c) The Plan does not pay any costs associated with the Sale,
including brokerage commissions, fees, appraisal costs, or any other
expenses.
(d) The terms and conditions of the Sale are at least as favorable
to the Plan as those it would have obtained in an arm's length
transaction with an unrelated party.
(e) The QIF must not have entered into, and must not enter into,
any agreement, arrangement, or understanding that includes any
provision that provides for the direct or indirect indemnification or
reimbursement of the QIF by the Plan or other party for any failure to
adhere to its contractual obligations or to state or Federal laws
applicable to the QIF's work; and the QIF may not seek or receive any
waiver of any rights, claims, or remedies of the Plan under ERISA,
state, or Federal law against the QIF with respect to the subject
matter of the exemption;
(f) The QIA must not have entered into, and must not enter into,
any agreement, arrangement, or understanding that includes any
provision that provides for the direct or indirect indemnification or
reimbursement of the QIA by the Plan or any other party for any failure
to adhere to its contractual obligations or to state or Federal laws
applicable to the QIA's work; and the QIA may not seek or obtain any
waiver of any rights, claims or remedies of the Plan or its
participants and beneficiaries under ERISA, the Code, or other Federal
and state laws against the QIA with respect to the subject matter of
the exemption;
(g) Prior to the Sale, Hawai[revaps]i Pacific Health (on behalf of
Straub) must pay back to the Plan the Property Expenses the Plan
erroneously paid from 2006 through 2014, including lost interest, in
violation of the Lease and PTE 81-71.\8\ Straub or Hawai[revaps]i
Pacific Health must pay the IRS the legally required excise tax for all
prohibited transactions conducted by the Plan from 2006 until 2022;
---------------------------------------------------------------------------
\8\ As noted above, Straub previously repaid the Plan the
Property Expenses the Plan erroneously paid from 2015 through 2022,
including lost interest.
---------------------------------------------------------------------------
(h) Straub and Hawai[revaps]i Pacific Health maintains for a period
of six (6) years from the date of Sale, in a manner that is convenient
and accessible for audit and examination, the records necessary to
enable the persons described in paragraph (i)(1) below to determine
whether conditions of this exemption have been met, except that (i) a
prohibited transaction will not be considered to have occurred merely
[[Page 54387]]
because, due to circumstances beyond the control of Straub,
Hawai[revaps]i Pacific Health, and/or the QIF, the records are lost or
destroyed prior to the end of the six-year period, and (ii) no party in
interest other than Straub, Hawai[revaps]i Pacific Health or the QIF
shall be subject to the civil penalty that may be assessed under ERISA
section 502(i) if the records are not maintained, or are not available
for examination as required by paragraph (i) below;
(i)(1) Except as provided in Section (2) of this paragraph and
notwithstanding any provisions of subsections (a)(2) and (b) of ERISA
section 504, the records referred to in paragraph (h) above shall be
unconditionally available at their customary location during normal
business hours to:
(i) any duly authorized employee or representative of the
Department or the Internal Revenue Service;
(ii) Straub, Hawai[revaps]i Pacific Health or any duly authorized
representative of Straub or Hawai[revaps]i Pacific Health;
(iii) the QIF or any duly authorized representative of the QIF;
(iv) any participant or beneficiary of the Plan, or any duly
authorized representative of such participant or beneficiary;
(j) Straub, Hawai[revaps]i Pacific Health and/or QIF must provide
to the Department the records necessary to demonstrate that the
conditions of the exemption have been met, within 30 days from the date
the Department requests such records; and
(k) All the material facts and representations made by the
Applicant that are set forth in the proposed exemption and this grant
notice must be true and accurate at all times.
Exemption date: The exemption will be in effect as of the date the
grant notice is published in the Federal Register.
Signed at Washington, DC, this 28th day of July 2026.
Christopher Motta,
Acting Director, Office of Exemption Determinations, Employee Benefits
Security Administration, U.S. Department of Labor
[FR Doc. 2026-17142 Filed 8-20-26; 8:45 am]
BILLING CODE 4510-29-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.